13F HOLDINGS REPORT
ARCH Venture Management, LLC
Quarter ended Q3 2023 · Filed August 9, 2023 · Accession 0001012975-23-000327
Total Value
$162.0M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | EQRX, INC. | 26886C107 | 36,335,375 | $67.6M | 41.73% |
| 2 | VERVE THERAPEUTICS, INC. | 92539P101 | 2,008,809 | $37.7M | 23.26% |
| 3 | ERASCA, INC. | ERAS | 11,055,554 | $30.5M | 18.84% |
| 4 | DENALI THERAPEUTICS, INC. | DNLI | 693,749 | $20.5M | 12.64% |
| 5 | SINGULAR GENOMICS SYSTEMS, INC. | 82933R100 | 3,798,926 | $3.2M | 1.95% |
| 6 | UNITY BIOTECHNOLOGY, INC. | UNTCW | 1,004,817 | $2.6M | 1.58% |